相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Application of the BRAT Framework to Case Studies: Observations and Insights
B. S. Levitan et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Development of a Framework for Enhancing the Transparency, Reproducibility and Communication of the Benefit-Risk Balance of Medicines
P. M. Coplan et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Anticoagulant Options - Why the FDA Approved a Higher but Not a Lower Dose of Dabigatran
B. Nhi Beasley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Understanding the receivers and the reception of science's uncertain messages
Philip Campbell
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES (2011)
Regulatory Challenges, Reimbursement, and Risk-Benefit Assessment
A. Breckenridge
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Weighing Risks and Benefits of Liraglutide -- The FDA's Review of a New Antidiabetic Therapy.
Mary Parks et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Bias modelling in evidence synthesis
Rebecca M. Turner et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY (2009)
A Multiattribute Model for Evaluating the Benefit-Risk Profiles of Treatment Alternatives
James C. Felli et al.
MEDICAL DECISION MAKING (2009)
Improving Communication of Uncertainty in the Reports of the Intergovernmental Panel on Climate Change
David V. Budescu et al.
PSYCHOLOGICAL SCIENCE (2009)
Balancing early market access to new drugs with the need for benefit/risk data: a mounting dilemma
Hans-Georg Eichler et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
A Theory of Medical Decision Making and Health: Fuzzy Trace Theory
Valerie F. Reyna
MEDICAL DECISION MAKING (2008)
A quantitative approach to benefit-risk assessment of medicines-part 1: The development of a new model using multi-criteria decision analysis
Filip Mussen et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)